首页 正文

Annual Trends in Medicare Part D Prescription Claims for Dupilumab 2017 to 2019

{{output}}
Disease control for moderate to severe atopic dermatitis (AD) has been primarily achieved with phototherapy and non-specific immunomodulators, cyclosporine, and methotrexate. These treatments have, however, been associated with many unfavorable side effects. ... ...